Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 11/20 | 0.85 |
| ▸ | MMP9 | P14780 | 10/20 | 0.85 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.85 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.74 |
| ▸ | MAPT | P10636 | 1/20 | 0.74 |
| ▸ | MMP1 | P03956 | 1/20 | 0.74 |
| ▸ | MMP3 | P08254 | 1/20 | 0.74 |
| ▸ | MMP7 | P09237 | 1/20 | 0.74 |
| ▸ | MMP13 | P45452 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.63 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.63 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4188026 | 1.00 | MMP2 (0.85) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL697592 | 1.00 | MMP2 (0.85) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL6545297 | 0.92 | MMP2 (1.00) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL1920507 | 0.92 | MMP2 (1.00) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL32691761 | 0.92 | MMP2 (1.00) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL8912956 | 0.91 | L3MBTL1 (0.78) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL3009406 | 0.90 | MMP2 (0.92) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL14218255 | 0.90 | MMP2 (0.79) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL8063645 | 0.90 | TDP1 (0.78) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 | |
| SCHEMBL697477 | 0.90 | MMP2 (0.79) | MMP2MMP9ADAMTS4ADAMTS5ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1457487-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | Toray Fine Chemicals Co., Ltd. (JP) | 2004-09-15 | — | — | EP | claimed |
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TORAY FINE CHEMICALS CO., LTD., A CORPORATION OF JAPAN, (JP) | 2004-09-02 | — | — | US | claimed |
| US-20040062773-A1 | Compositions for the delivery of antigens | EMISPHERE TECHNOLOGIES INC. | 2004-04-01 | — | — | US | claimed |
| EP-0784469-B1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECH INC (US) | 2004-03-24 | — | — | EP | claimed |
| US-6610329-B2 | Using acylated amino acid as carrier | EMISPHERE TECHNOLOGIES INC. | 2003-08-26 | — | — | US | claimed |
| US-20020001591-A1 | Compositions for the delivery of antigens | EMISPHERE TECHNOLOGIES, INC. | 2002-01-03 | — | — | US | claimed |
| US-5958457-A | MIXTURES OF ANTIGENS WITH ADJUVANTS AND ACYLATED AMINO ACIDS OR SALTS, POLYMERS OR SULFONATED AMINO ACIDS | EMISPHERE TECHNOLOGIES, INC. (US) | 1999-09-28 | — | — | US | claimed |
| EP-0784469-A4 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECH INC (US) | 1999-03-24 | — | — | EP | claimed |
| EP-0784469-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | Emisphere Technologies, Inc. (US) | 1997-07-23 | — | — | EP | claimed |
| WO-1996012474-A1 | COMPOSITIONS FOR THE DELIVERY OF ANTIGENS | EMISPHERE TECHNOLOGIES, INC. (US) | 1996-05-02 | — | — | WO | claimed |
| CN-105102430-A | Process for the preparation of enantiomerically enriched 3-aminopiperidine | REUTER CHEMISCHE APPBAU KG | 2015-11-25 | — | — | CN | disclosed |
| EP-2423211-B1 | PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF | KANEKA CORP (JP) | 2014-04-16 | — | — | EP | disclosed |
| EP-2423211-A1 | PROCESSES FOR PRODUCING (1S,6S)- OR (1R,6R)-CIS-2,8-DIAZABICYCLO[4.3.0]NONANE AND INTERMEDIATE THEREOF | Kaneka Corporation (JP) | 2012-02-29 | — | — | EP | disclosed |
| EP-1457487-A4 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | TORAY FINECHEMICALS CO LTD (JP) | 2005-06-22 | — | — | EP | disclosed |
| EP-1457487-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | Toray Fine Chemicals Co., Ltd. (JP) | 2004-09-15 | — | — | EP | disclosed |
| WO-2003053929-A1 | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE CIS-PIPERIDINE DERIVATIVES | TORAY FINE CHEMICALS CO., LTD. (JP) | 2003-07-03 | — | — | WO | disclosed |
| WO-2002085311-A2 | HCG FORMULATION | ACEVEDO HERNAN F (US) | 2002-10-31 | — | — | WO | disclosed |
| US-6271247-B1 | BINDING TO NEUROPEPTIDE RECEPTORS | ADIR ET COMPAGNIE (FR) | 2001-08-07 | — | — | US | disclosed |
| US-6172108-B1 | NEUROPEPTIDE Y RECEPTOR LIGANDS; TREATING PSYCHOLOGICAL, EATING, SLEEP, AND SEXUAL DISORDERS; HYPOTENSIVE, ANXIOLYTIC, ANTIDEPRESSANT, AND ANTIDIABETIC AGENTS | ADIR ET COMPAGNIE (FR) | 2001-01-09 | — | — | US | disclosed |
| CN-1260345-A | Hydrazide compound, its preparing method and medicine compositions thereof | ADIR ET COMPANGIE (FR) | 2000-07-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171836-A1 | Method for producing optical-active cis-piperidine derivatives | TYR, DDC, TARBP1 | MMP2 1206/4885MMP9 1373/4885ADAMTS4 2548/4885 |
| US-20020001591-A1 | Compositions for the delivery of antigens | CD47, CD74, LY96 | MMP2 2444/4885MMP9 2979/4885ADAMTS4 3212/4885 |
| US-20040062773-A1 | Compositions for the delivery of antigens | CD47, CD74, LY96 | MMP2 2444/4885MMP9 2979/4885ADAMTS4 3212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.